Literature DB >> 18690277

An ethical analysis of crisis in chronic pain care: facts, issues and problems in pain medicine; Part I.

James Giordano1, Michael E Schatman.   

Abstract

We posit that in order to realistically, fully, and most positively affect the capability of implementing a more comprehensive paradigm of pain care it is necessary to: 1) recognize the complexity of chronic pain; 2) account for economic factors imposed upon the healthcare system, and 3) enable articulation of any paradigmatic revision within the contemporary medico-legal environment. Three primary ethical problems arise from the interaction(s) of these contingencies--namely 1) the under-treatment of pain, 2) the inappropriate over-utilization of pharmacologic agents and techniques, and 3) tensions and conflicts that develop within the relationships of pain medicine. All can lead to a failure of technically apt and ethically sound pain care. This essay--the first in a 3-part series--employs the method of ethical analysis to approach the circumstances, issues, questions, and problems of contemporary practice of pain medicine, to allow insight(s) to the facts, define the agents involved, appreciate how problems are generated, and develop more thorough evaluation and articulation of potential resolutions. We contend that resolution of these problems must offer practical responses to the circumstances and issues. Such practicality entails affording "good" in ways that are grounded to the facts and realities of situations, and are not merely theoretical or conceptual. Determining the "good" is the work of ethics--as systems and analyses of the moral decisional process. Ethics establishes norms and articulates their use in practice, and we opine that the distinction between the normative and applied is more of a continuum that is dependent upon case and circumstance(s). Given the variety of circumstances in the practice of pain medicine, no single ethical system would be totally adequate, and we believe a discursive approach to be most effective. Subsequent papers in this series will describe the systems, structure, and function of a putative ethical infrastructure of pain medicine, and will attempt to illustrate how these could be articulated within an integrative paradigm of pain care.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690277

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  8 in total

1.  Ethical challenges and interventional pain medicine.

Authors:  Gary J Brenner; Karsten Kueppenbender; Jianren Mao; Jeffrey Spike
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  The 2010 Annual Conference of the Canadian Pain Society.

Authors: 
Journal:  Pain Res Manag       Date:  2010 Mar-Apr       Impact factor: 3.037

3.  Managing pain in inflammatory bowel disease.

Authors:  Michael J Docherty; R Carter W Jones; Mark S Wallace
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

4.  The health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitability.

Authors:  Michael E Schatman; Lynn R Webster
Journal:  J Pain Res       Date:  2015-03-18       Impact factor: 3.133

5.  The American chronic pain crisis and the media: about time to get it right?

Authors:  Michael E Schatman
Journal:  J Pain Res       Date:  2015-12-17       Impact factor: 3.133

6.  A glimmer of hope in American pain medicine?

Authors:  Michael E Schatman
Journal:  J Pain Res       Date:  2016-07-13       Impact factor: 3.133

7.  Ethical decision making in pain management: a conceptual framework.

Authors:  Ana Sofia Carvalho; Sandra Martins Pereira; António Jácomo; Susana Magalhães; Joana Araújo; Pablo Hernández-Marrero; Carlos Costa Gomes; Michael E Schatman
Journal:  J Pain Res       Date:  2018-05-15       Impact factor: 3.133

8.  Manifestation of Borderline Personality Symptomatology in Chronic Pain Patients Under Stress: An Understated and Exacerbated Consequence of the COVID-19 Crisis.

Authors:  Hannah Shapiro; Ronald J Kulich; Michael E Schatman
Journal:  J Pain Res       Date:  2020-06-15       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.